CogState Saham

CogState Beban Bunga

Delisted·15 Jun 2026

Beban Bunga dari CogState (CGS.AX) pada 16 Agu 2026 adalah 834.200,00 USD. Tahun sebelumnya, Beban Bunga adalah 27.300,00 USD — perubahan sebesar 2.955,68% (lebih tinggi).

Beban Bunga

834.200,00USD

YoY

2.955,68%

Terakhir Diperbarui:

Beban Bunga dari CogState adalah 2026 834.200,00 USD. Beban Bunga dari CogState adalah 2025 27.300,00 USD. Menurun 2.955,68% lebih tinggi dibandingkan dengan tahun sebelumnya.
Access this data via the Eulerpool API

CogState Analisis saham

Apa yang dilakukan CogState? CogState Ltd is an Australian company specializing in the development of innovative cognitive tests. The company was founded in 1999 and is based in Melbourne, Australia. It conducts computer-based cognitive tests to gather information about the cognitive functioning of patients and athletes. The CogState tests are specifically designed to measure cognitive abilities in areas such as perception, reaction time, memory, and attention. The business model of CogState is based on the development, marketing, and sale of cognitive test products. The company generates a significant portion of its revenue through licensing its tests to pharmaceutical and biotech companies that want to test their medications or therapies more effectively. CogState also has a strong presence in the sports industry, offering its tests to sports teams and individual athletes. CogState was founded in 1999 by Paul Maruff, a neuropsychologist, who was searching for better and more effective ways to conduct cognitive tests. Initially, the tests developed by CogState were exclusively for medical research, but it was quickly discovered that they could be useful in other areas as well. In 2004, Richard Kimber joined the company as CEO and Chairman, bringing his experience from the biotechnology industry. CogState offers a variety of cognitive tests for various applications, including clinical trials, sports performance analysis, and brain injury treatment. The tests are licensed by different companies and organizations that use them to test the effects of medications and therapies on cognitive functions or to assess performance and injuries in sports. One example of a CogState product is the AX Continuous Tracker Test. This test was developed for clinical use and allows for continuous and accurate measurement of cognitive functions in patients with psychiatric and neurological disorders. Another application is the SPARQ test for athletes, which allows for the measurement and improvement of athletes' cognitive abilities. In summary, CogState Ltd is a leading company in the field of cognitive tests. The company specializes in developing innovative cognitive tests for the specific requirements of pharmaceutical and biotech companies, as well as sports organizations. The tests are used worldwide by various organizations and have a significant impact on the treatment of psychiatric and neurological disorders, as well as performance and injury analysis in sports. CogState adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham CogState

Beban Bunga CogState adalah 834.200,00 USD pada tahun 2026.

Beban Bunga dari CogState berubah dari 27.300,00 USD menjadi 834.200,00 USD, mewakili perubahan 2.955,68%. Nilainya lebih tinggi daripada tahun sebelumnya.

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap Beban Bunga CogState sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

Beban bunga mewakili biaya peminjaman. Beban bunga yang lebih tinggi dapat menunjukkan perusahaan yang sangat terleverage.

USD Beban Bunga adalah faktor kunci bagi investor. Perubahan metrik ini dapat menunjukkan fundamental yang membaik atau memburuk, secara langsung memengaruhi harga saham. Di Eulerpool, Anda dapat melacak CogState Beban Bunga secara historis dan real-time.

Access this data via the Eulerpool API

Laporan Laba Rugi — CogState

Semua Metrik Kunci — CogState